Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Transcranial Doppler Screening of Children with Sickle Cell Disease for a Large, Multinational Interventional Study: Experience from the Phase 3 HOPE-Kids 2 Trial Investigating the Effect of Voxelotor Treatment on Transcranial Doppler Flow Velocity

Blood (2023) 142 (Supplement 1): 3871.

https://doi.org/10.1182/blood-2023-188677

Published: 2023

Journal Articles

Initial Safety and Efficacy Results from the Phase II, Multicenter, Open-Label Solace-Kids Trial of Crizanlizumab in Adolescents with Sickle Cell Disease (SCD)

Matthew M. Heeney, David C. Rees, Mariane De Montalembert, Isaac Odame, R. Clark Clark Brown, Yasser Wali, Thu Thuy Nguyen, Du Lam, Nadege Pfender, Julie Kanter

Blood (2021) 138 (Supplement 1): 12.

https://doi.org/10.1182/blood-2021-144730

Published: 2021

Journal Articles

Study Design and Initial Baseline Characteristics in Solace-Kids: Crizanlizumab in Pediatric Patients with Sickle Cell Disease

Matthew M. Heeney, MD, David C. Rees, MD, Mariane de Montalembert, MD PhD, Isaac Odame, MD, R. Clark Brown, MD PhD, Yasser Wali, MD, Thu Thuy Nguyen, Du Lam, MD, Raquel Merino Herranz, Julie Kanter, MD

Blood (2020) 136 (Supplement 1): 22–24.

https://doi.org/10.1182/blood-2020-137081

Published: 2020

Journal Articles

Prevalence, Clinical Characteristics and Outcome of Von Willebrand Disease in Oman

Shamsa Alkaabi, Aala Alzadjali, Mustafa Wasifuddin, Ibrahim Suliman Masoud Alghaithi, MD, Murtadha Al-Khabori, MD, Anil Pathare, MD PhD FCPS, MBBS, Yasser Wali, MD

Blood (2019) 134 (Supplement_1): 4939.

https://doi.org/10.1182/blood-2019-123915

Published: 2019

Journal Articles

"Prevalence and Outcome of Avascular Necrosis of the Hip (AVN) Among Young Omani Patients with Sickle Cell Disease"

Iman Al Fadhali, Farah Al-Kindy, MD, Naema Alshibli, Salam Alkindi, FRCP, BA, MBBChir, Murtadha Al-Khabori, MD, Abdulhakim Al Rawas, Asma Al Shezawi, Yasser Mahfouz, Surekha Tony Mevada, Yasser Wali

Blood (2019) 134 (Supplement_1): 3577.

https://doi.org/10.1182/blood-2019-127875

Published: 2019

Journal Articles

Clinical and Magnetic Resonance Imaging (MRI) Decision Making Rules in Differentiating Vaso-Occlusive Crises (VOCs) from Osteomyelitis in Paediatric Sickle Cell Population: Is MRI Pathognomonic?

Ahmed khalifa Al Shukaili, MD, Ahmed Abdullah Al Kharusi, MD, Eyad Tbaileh, MD, Hanan Nazir, Sameer Raniga, Alaa Al Manzalawy, Mohamed Ebrahim Mohamed Ebrahim Elshinawy, MD, Zaid Al Hinai, Laila Al Yazidi, Murtadha Al-Khabori, MD, Yasser Wali

Blood (2019) 134 (Supplement_1): 4824.

https://doi.org/10.1182/blood-2019-130861

Published: 2019

Journal Articles

The Optimal Cut-Off Level for Hemoglobin A2 to Differentiate between Sickle Cell Disease Genotypes

Fayiz Al Shueili, MD, Murtadha K. Al-Khabori, BSc,MD FRCPC, MSc, Salam Al-Kindi, Yasser Wali, MD, Shoaib Al-Zadjali, PhD

Blood (2018) 132 (Supplement 1): 2391.

https://doi.org/10.1182/blood-2018-99-118697

Published: 2018

Journal Articles

Impact of Treatment Regimen with Moroctocog Alfa (AF-CC) on Bleeding Frequency in Pediatric Aged Subjects with Moderately Severe to Severe Hemophilia A

Mark P. Smith, MD FRACP, FRCPA, Jeremy Rupon, MD, Yasser Wali, MD, Hala Remawi, MD, Joan Korth-Bradley, PharmD, PhD, Lynne Smith, MBA, Pablo Rendo, MD

Blood (2018) 132 (Supplement 1): 1205.

https://doi.org/10.1182/blood-2018-99-111891

Published: 2018

Journal Articles

Avascular Necrosis of the Femoral Head in Sickle Cell Disease in Egypt and Oman: A Cross Sectional Study

Mohsen Saleh Elalfy, MD, Iman Fadhli, Shaimaa Mohammad, Aida Ali, Naema Shibli, Farah Kindi, Sultan Almaskari, Yasser Wali, MD

Blood (2018) 132 (Supplement 1): 4921.

https://doi.org/10.1182/blood-2018-99-116683

Published: 2018

Journal Articles

An Observational, Non-Interventional, Multicentre Study of Immune Thrombocytopenia: The Africa Middle East and Asian Immune Thrombocytopenia Registry

Faisal Alsayegh, BMBCH, Mohammed Qari, Mervat Matar, Yasser Wali, Muhammad Kanani, Ali Al Madhani, Ibrahim Al Hijji, Doaa El Demerdash, Mahmoud Abbas

Blood (2017) 130 (Supplement 1): 4861.

https://doi.org/10.1182/blood.V130.Suppl_1.4861.4861

Published: 2017

Journal Articles

Sickle Cell Disease Patients with Systemic Lupus Erythematosus Exhibit Quantitative and Qualitative Impairments in Circulating B Regulatory Cells

Amal Al-Naamani, Ahmed Al-Yarabi, Nasser Ambu-Ali, Tahar Al-Shabibi, Zahra Al-Qarni, Nasra Al-Obaidani, Hamad Khan, Juma K Al-Kaabi, Jalila Al-Shekaili, Amar Oukil, Sulaiman Ali Al-Hashmi, Alya Al-Ansari, Fahad Al-Zadjali, Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Khalil Al-Farsi, MD, Mohammed N. Alhuneini, MD BSc, FRCP, Yasser Wali, Salam Al-Kindi, Mohamed-Rachid Boulassel, DEMS, PhD

Blood (2016) 128 (22): 3641.

https://doi.org/10.1182/blood.V128.22.3641.3641

Published: 2016

Journal Articles

Influence of Genetic Modifiers on Levels of Invariant Natural Killer T-Cells in Patients with Sickle Cell Anemia

Ahmed Al-Yarabi, Tahar Al-Shabibi, Nasser Ambu-Ali, Shoaib Al-Zadjali, Abeer Al-Zubaidi, Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Mohammed Al-Huneini, Salam Al-Kindi, Yasser Wali, Mohamed-Rachid Boulassel, DEMS, PhD

Blood (2016) 128 (22): 4843.

https://doi.org/10.1182/blood.V128.22.4843.4843

Published: 2016

Journal Articles

Circulating Invariant Natural Killer T Cell Subsets Are Functionally Preserved in Splenectomized Children with Sickle Cell Disease Compared to Patients with Large Spleen

Mohamed-Rachid Boulassel, DEMS, PhD, Abeer Al-Zubaidi, Ismail Beshlawi, Zahra Al-Qarni, Nidaa Al-Naamany, Shoaib Al-Zadjali, Sulaiman Al-Hashmi, Hamad Khan, Mohammed Al Huneini, Khalil Al Farsi, Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Salam Al-Kindi, Yasser Wali

Blood (2015) 126 (23): 3389.

https://doi.org/10.1182/blood.V126.23.3389.3389

Published: 2015

Journal Articles

Liver Enzymes Changes and Safety Profile of Deferasirox Iron Chelator in Omani Children with Thalassemia Major

Surekha Tony Mevada, MD, Abdaluziz Sulieman AlDhuli, A.Hakim Al-Rawas, MD, Murtadha K. Al-Khabori, BSc, MD FRCPC, Hanan Nazir, MD, Mathew Zachariah, MD, Prof. Yasser Wali, MD FRCPCH, (UK)

Blood (2014) 124 (21): 4903.

https://doi.org/10.1182/blood.V124.21.4903.4903

Published: 2014

Journal Articles

Delivering a Hemophilic Newborn with No Intracranial Hemorrhage: Is Caesarian Section the Answer?

Hanan Nazir, MD, Tuqa Allawati, Ismail Elbeshlawi, Murtadha K. Al-Khabori, MD MSc, FRCPC, Sara Alkindi, Wafa Alriyami, Prof. Yasser Wali, MD FRCPCH, (UK)

Blood (2014) 124 (21): 5060.

https://doi.org/10.1182/blood.V124.21.5060.5060

Published: 2014

Journal Articles

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Mohsen Saleh Elalfy, Yasser Wali, MD, FRCPCH, (UK), S Tony, Ahmed Samir, Amira Adly

Blood (2013) 122 (21): 559.

https://doi.org/10.1182/blood.V122.21.559.559

Published: 2013

Journal Articles

Outcome of Early Introduction of Hypertransfusion/Chelation Program in Children with Thalassemia Intermedia

Yasser Wali, MD, FRCPCH, (UK), A. Hakim Al-Rawas, MD, Shoaib Al Zadjali, M Sc, Murtadha K. Al-Khabori, MD, MSc, FRCPC, Wafa Bashir, MD, Mathew Zachariah, MD, Taimoora Sulaiman, MD, Surekha Tony, MD

Blood (2012) 120 (21): 3260.

https://doi.org/10.1182/blood.V120.21.3260.3260

Published: 2012

Journal Articles

Optimizing Hydroxyurea Use in Children with Sickle Cell Disease: Least Tolerated Dose Is Effective

Sharef Waadallah Sharef, MD, Maya Al-Hajri, MD, Ismail Beshlawi, MBChB, MM Ped, Amer Qais Al-Shahrabally, FABP, FIBP, MBChB, Yasser Wali, MD, FRCPCH, (UK)

Blood (2011) 118 (21): 4851.

https://doi.org/10.1182/blood.V118.21.4851.4851

Published: 2011

Journal Articles

Dose Optimization of Deferasirox in Chelation Naïve Children with Thalassemia Major

Surekha Tony, MD, Murtadha K. Al-Khabori, MD, FRCPC, Ashraf Abdullah Saad, MBBS, Shahina Daar, MD, PhD, Mathew Zachariah, MD, Yasser Wali, MD, FRCPCH, (UK)

Blood (2011) 118 (21): 5294.

https://doi.org/10.1182/blood.V118.21.5294.5294

Published: 2011

Journal Articles

T2* MRI in Hypertransfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect the Reality

Surekha Tony, MD, Shahina Daar, MD, PhD, Shoaib Al Zadjali, MSc, Murtadha K. Al-Khabori, MD, FRCPC, Mohammed El Shinawy, MD, Yasser Wali, MD, FRCPCH, (UK)

Blood (2011) 118 (21): 5304.

https://doi.org/10.1182/blood.V118.21.5304.5304

Published: 2011

NARROW

Transcranial Doppler Screening of Children with Sickle Cell Disease for a Large, Multinational Interventional Study: Experience from the Phase 3 HOPE-Kids 2 Trial Investigating the Effect of Voxelotor Treatment on Transcranial Doppler Flow Velocity

Initial Safety and Efficacy Results from the Phase II, Multicenter, Open-Label Solace-Kids Trial of Crizanlizumab in Adolescents with Sickle Cell Disease (SCD)

Study Design and Initial Baseline Characteristics in Solace-Kids: Crizanlizumab in Pediatric Patients with Sickle Cell Disease

Prevalence, Clinical Characteristics and Outcome of Von Willebrand Disease in Oman

"Prevalence and Outcome of Avascular Necrosis of the Hip (AVN) Among Young Omani Patients with Sickle Cell Disease"

Clinical and Magnetic Resonance Imaging (MRI) Decision Making Rules in Differentiating Vaso-Occlusive Crises (VOCs) from Osteomyelitis in Paediatric Sickle Cell Population: Is MRI Pathognomonic?

The Optimal Cut-Off Level for Hemoglobin A2 to Differentiate between Sickle Cell Disease Genotypes

Impact of Treatment Regimen with Moroctocog Alfa (AF-CC) on Bleeding Frequency in Pediatric Aged Subjects with Moderately Severe to Severe Hemophilia A

Avascular Necrosis of the Femoral Head in Sickle Cell Disease in Egypt and Oman: A Cross Sectional Study

An Observational, Non-Interventional, Multicentre Study of Immune Thrombocytopenia: The Africa Middle East and Asian Immune Thrombocytopenia Registry

Sickle Cell Disease Patients with Systemic Lupus Erythematosus Exhibit Quantitative and Qualitative Impairments in Circulating B Regulatory Cells

Influence of Genetic Modifiers on Levels of Invariant Natural Killer T-Cells in Patients with Sickle Cell Anemia

Circulating Invariant Natural Killer T Cell Subsets Are Functionally Preserved in Splenectomized Children with Sickle Cell Disease Compared to Patients with Large Spleen

Liver Enzymes Changes and Safety Profile of Deferasirox Iron Chelator in Omani Children with Thalassemia Major

Delivering a Hemophilic Newborn with No Intracranial Hemorrhage: Is Caesarian Section the Answer?

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Outcome of Early Introduction of Hypertransfusion/Chelation Program in Children with Thalassemia Intermedia

Optimizing Hydroxyurea Use in Children with Sickle Cell Disease: Least Tolerated Dose Is Effective

Dose Optimization of Deferasirox in Chelation Naïve Children with Thalassemia Major

T2* MRI in Hypertransfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect the Reality

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only